• Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Recommendation of "Moderate Buy" by Analysts

    Source: Buzz FX / 22 Jan 2025 01:50:17   America/Chicago


    Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Given Average Recommendation of "Moderate Buy" by Analysts Written by MarketBeat January 22, 2025 Share Link copied to clipboard. Syndax Pharmaceuticals, Inc.
    Read more...
Share on,